It's not hard to come up with that $15 target.
The current market size is around US$4.5bill and growing.
Given Spontan's clear advantages, it is not difficult to think that it could reach at least a 2-3% market share reasonably quickly. It definitely might be able to do better.
3% of US$4.5bill is US$135mill. This is a very high margin product. Gross profit could exceed 90% or US$121.5mill
That's A$181mill. I'm allowing 15% of that GP ($27mill) is spent on overheads and R&D.
That would leave NPBT of A$154mill and NPAT of A$108mill if paying the full 30% tax rate.
I'd expect strong year on year growth and therefore a potential PE of 20. That would require a market cap of A$2.157bill and a sp of $13.
A 5% market share bumps my sp target to $21.70.
These are unrisked targets. They still need regulatory approval and then to deliver the market share so I'd expect a very volatile ride.
- Forums
- ASX - By Stock
- LTP
- Valuation
LTP
ltr pharma limited
Add to My Watchlist
5.45%
!
29.0¢

Valuation, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.015(5.45%) |
Mkt cap ! $32.46M |
Open | High | Low | Value | Volume |
27.5¢ | 29.0¢ | 27.5¢ | $134.1K | 482.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 7400 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.285 |
2 | 38320 | 0.275 |
20 | 366495 | 0.270 |
4 | 52902 | 0.265 |
6 | 40816 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 7400 | 2 |
0.300 | 42597 | 2 |
0.305 | 9760 | 1 |
0.310 | 17286 | 2 |
0.320 | 36858 | 4 |
Last trade - 15.19pm 25/06/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |